Test Price
2,800 AED✅ Home Collection Available
VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
✅ 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing
🏥 Premium Home Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily)
📞 Post-test Telephonic Clinical Guidance by DHA-licensed Consultant Medical Geneticist
💳 Direct Insurance Billing – WhatsApp verification: +971 54 548 8731
Test Overview & Methodology
The VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test analyzes the entire coding region of the VRK1 gene using next‑generation sequencing (NGS) to identify pathogenic variants linked to this severe autosomal recessive neurodevelopmental disorder. This targeted panel provides comprehensive coverage of all coding exons ±10 base pairs with a diagnostic yield exceeding 99%.
| Feature | Our VRK1 NGS Test (DNA Labs UAE) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Methodology | Targeted NGS panel – full VRK1 gene | Whole exome capture + sequencing |
| Diagnostic Yield | >99% coverage of coding exons ±10 bp | Variable; incidental findings possible |
| Turnaround Time | 3–4 Weeks | 8–12 Weeks |
| Cost (UAE) | 2,800 AED | 5,000–7,000 AED |
Physician Insight & Safety Protocols
“This targeted VRK1 gene test is essential for confirming the diagnosis in infants with microcephaly, cerebellar hypoplasia, and severe developmental delay. A negative result does not exclude other subtypes of pontocerebellar hypoplasia, and clinical correlation remains paramount. Our team is committed to supporting families throughout the diagnostic journey with expertise and compassion.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Important Safety Information
⚠️ Do not discontinue prescribed medications without consulting your treating physician. If acute neurological deterioration (loss of consciousness, prolonged seizures, respiratory distress) occurs, call 998 immediately rather than waiting for test results.
Exclusion Criteria & Red Flags
- Asymptomatic adults without a family history of pontocerebellar hypoplasia; genetic counseling is mandatory prior to testing.
- Minors who cannot consent must have a legal guardian present; informed consent must be obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- If the patient experiences acute neurological deterioration (e.g., loss of consciousness, prolonged seizures, respiratory distress), do not wait for test results – call 998 immediately.
- Test is not suitable for somatic mosaicism detection; a whole blood or extracted DNA sample is required.
Patient FAQ & Clinical Guidance
1. Who should undergo VRK1 gene testing for pontocerebellar hypoplasia type 1A?
Any infant presenting with microcephaly, cerebellar hypoplasia, and severe psychomotor delay should undergo VRK1 genetic analysis. Genetic counseling is recommended both before and after testing.
2. How accurate is this genetic test for VRK1 mutations?
The test achieves >99.9% diagnostic sensitivity for known pathogenic variants in the VRK1 gene using ISO‑validated NGS chemistry, with >99% coverage of all coding exons and flanking intronic regions.
3. What sample is needed and how is home phlebotomy arranged?
We accept whole blood, extracted DNA, or dried blood spot on an FTA card. Our VIP mobile phlebotomy team collects the sample at your doorstep between 8 AM and 11 PM under temperature-controlled cold‑chain conditions.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This genetic testing service adheres strictly to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of genetic and clinical data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing telemedicine and digital health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – covering informed consent and patient safety.
Laboratory accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or dried blood spot (FTA card) VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM) |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) – full VRK1 gene coding region ±10 bp |
| ICD-10-CM Code | Q04.8 (Other specified congenital malformations of brain) |
| LOINC Code | 95411-6 (VRK1 gene mutation analysis) |
| DHA Facility License & Address | DHA License No: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians